Preparation of stearic acid solid lipid nanoparticles containing podophyllotoxin

Abstract

Abstract: Objective To improve the therapeutic efficacy and reduce the adverse effect of podophyllotoxin (PPT) by wrapping it in stearic acid solid lipid nanoparticles. Methods Stearic acid solid lipid nanoparticles containing podophyllotoxin was prepared using modified microemulsion technique, whose morphology was examined by transmission electron microscope. High-performance of liquid chromatography was employed to determine the entrapment efficiency of PPT in the nanoparticles. Results The entrapment efficiency of PPT in the nanoparticles was 85.6% and the mean diameter of the particles was 56.5±25.8 nm. Conclusion The stearic acid solid lipid nanoparticles has high entrapment efficiency for PPT and is homogeneous in size, which can be a promising targeted preparation for epidermal delivery.

CLC Number:

R979.19
R986

XIE Fang-ming¹, ZENG Kang¹, LI Guo-feng², LIN Zhong-fang¹, SUN Le-dong¹. Preparation of stearic acid solid lipid nanoparticles containing podophyllotoxin[J]. Journal of Southern Medical University, 2005, 25(01): 99-101.

References

[1] Kinghorn GR, McMillan A, Mulcahy F, et al. An open comparative study of the efficacy of 0.5% podophyllotoxin lotion and 25%podophyllotoxin solution in the treatment of condylomata acuminata in males and females[J]. Iht J STD AIDS, 1993, 4(2): 194-9.
[2] Petersen CS, Weismann K, Quercetin, et al. An argument against the use of podophyllin [J] ? Genitourin Med, 1995,71 (2): 92-3.
[3] Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery -a review of the state of the art [J]. Eur J Pharm Biopharm, 2000, 50(1): 161-77.
[4] zur Muhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery -drug release and release mechanism[J]. Eur J Pharm Biopharm, 1998, 45(2): 149-55.
[5] Dingler A, Blum RP, Niehus H, et al. Solid lipid nanoparticles (SLN/Lipopearls) -a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products [J]. J Microencapsul, 1999, 16(6): 751-67.
[6] Gasco MR. Method for producing solid lipid microspheres having a narrow distribution[P]. USP: 5 250 236, 1993.
[7] Chen DB, Yang TZ, Lu WL, et al. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel[J]. Chem Pharm Bull (Tokyo), 2001, 49(11): 1444-7.
[8] Strand A, Wilander E, Zehbe I, et al. High risk HPV persists after treatment of genital papillomavirus infection but not after treatment of cervical intraepithelial neoplasia [J]. Acta Obstet Gynecol Scand,1997,76(2): 140-4.
[9] 曾抗,李国锋,许重远,等.鬼臼毒素脂质体软膏治疗尖锐湿疣的双盲随机对照试验[J].第一军医大学学报,1998,18(3):246.Zeng K, Li GF, Xu CY, et al. Dual blinded random control experiment of podophyllotoxin liposome cream for treating condyloma accuminatum [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 1998, 18(3): 246.
[10] 江彬彬,曾抗,张三泉,等.鬼臼毒素二棕榈酸磷脂酰胆碱脂质体局部外用的实验研究[J].第一军医大学学报,2002,22(10):875-7.Jiang BB, Zeng K, Zhang SQ, et al. Experimental study of podophyllotoxin dipalmitoylphosphatidylcholine liposome for topical skin application[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 22(10): 875-7.
[11] Jenning V, Gysler A, Schafer-Korting M, et al. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin [J]. Eur J Pharm Biopharm, 2000,49(3): 211-8.
[12] Jenning V, Schafer-Korting M, Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties [J]. J Control Release, 2000, 66(2-3): 115-26.
[13] Mei Z, Chen H, Weng T, et al. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide [J]. Eur J Pharm Biopharm, 2003, 56(2): 189-96.
[14] Wang J, Chen DB, Zhang Q. Determination of surface properties and cell uptake in vivo of stearic acid solid lipid nanoparticle[J]. Chin Pharm J, 36(2): 102-6.